MYOCARDIAL BETA-ADRENOCEPTOR FUNCTION AND REGULATION IN HEART-FAILURE - IMPLICATIONS FOR THERAPY

[1] AARONS RD, 1982, J PHARMACOL EXP THER, V221, P439

[2] A RANDOMIZED TRIAL OF LOW-DOSE BETA-BLOCKADE THERAPY FOR IDIOPATHIC DILATED CARDIOMYOPATHY [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (04) : 471 - 475

[3] PRENALTEROL IS AN AGONIST AT BETA-2-ADRENOCEPTOR AS WELL AS AT BETA-1-ADRENOCEPTORS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 81 (04) : 659 - 663

[4] ARIENS EJ, 1981, TRENDS PHARMACOL SCI, V2, P170, DOI 10.1016/0165-6147(81)90302-3

[5] FUNCTIONAL BETA-1-ADRENOCEPTORS AND BETA-2-ADRENOCEPTORS IN THE HUMAN MYOCARDIUM [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 123 (01): : 81 - 88

[6] BARNETT D B, 1986, British Journal of Pharmacology, V87, p223P

[7] ACUTE HEMODYNAMIC AND METABOLIC EFFECTS OF ICI-118,587 (CORWIN), A SELECTIVE PARTIAL BETA-1 AGONIST, IN PATIENTS WITH DILATED CARDIOMYOPATHY [J]. AMERICAN HEART JOURNAL, 1986, 111 (04) : 692 - 696

[8] ROLE OF CYCLIC-AMP IN CARDIAC BETA-ADRENOCEPTOR DESENSITIZATION - STUDIES USING PRENALTEROL AND INHIBITORS OF PHOSPHODIESTERASE [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (05) : 795 - 801

[9] IMPAIRED LEFT-VENTRICULAR DIASTOLIC FILLING IN PATIENTS WITH CORONARY-ARTERY DISEASE - ASSESSMENT WITH RADIONUCLIDE ANGIOGRAPHY [J]. CIRCULATION, 1981, 64 (02) : 315 - 323

[10] BETA-1-ADRENERGIC-RECEPTOR AND BETA-2-ADRENERGIC-RECEPTOR SUBPOPULATIONS IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM - COUPLING OF BOTH RECEPTOR SUBTYPES TO MUSCLE-CONTRACTION AND SELECTIVE BETA-1-RECEPTOR DOWN-REGULATION IN HEART-FAILURE- [J]. CIRCULATION RESEARCH, 1986, 59 (03) : 297 - 309

[1] AARONS RD, 1982, J PHARMACOL EXP THER, V221, P439

[2] A RANDOMIZED TRIAL OF LOW-DOSE BETA-BLOCKADE THERAPY FOR IDIOPATHIC DILATED CARDIOMYOPATHY [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (04) : 471 - 475

[3] PRENALTEROL IS AN AGONIST AT BETA-2-ADRENOCEPTOR AS WELL AS AT BETA-1-ADRENOCEPTORS [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 81 (04) : 659 - 663

[4] ARIENS EJ, 1981, TRENDS PHARMACOL SCI, V2, P170, DOI 10.1016/0165-6147(81)90302-3

[5] FUNCTIONAL BETA-1-ADRENOCEPTORS AND BETA-2-ADRENOCEPTORS IN THE HUMAN MYOCARDIUM [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 123 (01): : 81 - 88

[6] BARNETT D B, 1986, British Journal of Pharmacology, V87, p223P

[7] ACUTE HEMODYNAMIC AND METABOLIC EFFECTS OF ICI-118,587 (CORWIN), A SELECTIVE PARTIAL BETA-1 AGONIST, IN PATIENTS WITH DILATED CARDIOMYOPATHY [J]. AMERICAN HEART JOURNAL, 1986, 111 (04) : 692 - 696

[8] ROLE OF CYCLIC-AMP IN CARDIAC BETA-ADRENOCEPTOR DESENSITIZATION - STUDIES USING PRENALTEROL AND INHIBITORS OF PHOSPHODIESTERASE [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (05) : 795 - 801

[9] IMPAIRED LEFT-VENTRICULAR DIASTOLIC FILLING IN PATIENTS WITH CORONARY-ARTERY DISEASE - ASSESSMENT WITH RADIONUCLIDE ANGIOGRAPHY [J]. CIRCULATION, 1981, 64 (02) : 315 - 323

[10] BETA-1-ADRENERGIC-RECEPTOR AND BETA-2-ADRENERGIC-RECEPTOR SUBPOPULATIONS IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM - COUPLING OF BOTH RECEPTOR SUBTYPES TO MUSCLE-CONTRACTION AND SELECTIVE BETA-1-RECEPTOR DOWN-REGULATION IN HEART-FAILURE- [J]. CIRCULATION RESEARCH, 1986, 59 (03) : 297 - 309